My ePortfolio Register   

Cancer Institutes - Publications

The latest oncology research from European Institutes; constantly updated from PubMed indexed journals. Details of participating Institutes can be found at the 'By Institute' tab below.

Details of participating institutes can be found on the By Institute tab below.

Evaluation of the effectiveness of (18)F-FDG-PET/CT examination of head and neck cancer - own experience.

E Majchrzak, W Cholewiński, B Szybiak, L Luczewski, M Sówka, P Golusiński, W Golusiński

Otolaryngol Pol 2013 10.1016/j.otpol.2012.10.002

Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4.

N Ty, R Pontikis, GG Chabot, E Devillers, L Quentin, S Bourg, JC Florent

Bioorg. Med. Chem. 2012 10.1016/j.bmc.2012.11.056

Positron emission tomography/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis?

AR Cervino, L Evangelista, R Alfieri, C Castoro, VC Sileni, F Pomerri, L Corti, PC Muzzio

J Cancer Res Ther 2012 10.4103/0973-1482.106580

The factors that have an impact on the development of brain metastasis in the patients with breast cancer.

A Dayan, D Koca, T Akman, I Oztop, H Ellidokuz, U Yilmaz

J Cancer Res Ther 2012 10.4103/0973-1482.106531

Impact of intravascular volume replacement and transfusion on outcome: Where are we now?

P Leme Silva, P Pelosi, M Gama de Abreu

Best Pract Res Clin Anaesthesiol 2012 10.1016/j.bpa.2012.11.004

Cutaneous metastasis from hepatocellular carcinoma.

J Syrios, M Logothetis, H Tountas, A Grivas, E Lianos, AE Athanasiou

J BUON 2012

Surgical management of endometrial cancer. A critical review.

E Halkia, N Kalinoglou, J Spiliotis

J BUON 2012

Expression of Genes of Glutathione Transferase Isoforms GSTP1-1, GSTA4-4, and GSTK1-1 in Tumor Cells during the Formation of Drug Resistance to Cisplatin.

EV Kalinina, TT Berozov, AA Shtil, NN Chernov, VA Glasunova, MD Novichkova, NK Nurmuradov

Bull. Exp. Biol. Med. 2012

[Sexuality and intimacy after cancer: an explorative survey at 5 years or more since treatment completion].

B Muzzatti, L Giovannini, C Flaiban, MA Annunziata

G Ital Med Lav Ergon 2012



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence